January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 13, 2025

JAK Inhibitors & RZV Vaccination Timing: Study Underway

"The risk of developing herpes zoster is confirmed in almost all studies regarding JAK inhibitors."

Conexiant

January 10, 2025

Higher H. pylori Prevalence Seen in Severe Psoriasis

Psoriasis patients show higher Helicobacter pylori infection rates, with potential implications for further research into disease associations.

Conexiant

January 10, 2025

Remission Key to Successful Glucocorticoid Tapering

Discover how remission, hydroxychloroquine use, and gradual glucocorticoid tapering reduce flare risks in systemic lupus erythematosus.

Conexiant

January 07, 2025

Quirky Clinic: Regrowing Tonsils, Plastic-Infused Tea, & More

Can tonsils grow back? Are we drinking billions of nanoplastics in the name of wellness? Is fungi in the nose the culprit to sniffles? We explore these questions and more.

Conexiant

April 29, 2024

First Death From Alaskapox Reported

Alaska health officials warned of the risk of Alaskapox in the wake of the first death from the disease in January 2024.

Conexiant

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

June 06, 2024

Advances in Corneal Transplant Techniques

Explore new techniques in corneal transplantation, including Descemet’s membrane endothelial keratoplasty and artificial corneas, for treating corneal diseases.

Conexiant